Evgeny Stavnichy was appointed Director of Immunopreparat Ufa enterprise, the largest NPO Microgen subsidiary.
Evgeny Stavnichy graduated from K.I. Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology majoring in Veterinary Medicine, has a degree of Ph.D (Biology).
From 2000 to 2004 Evgeny Stavnichy worked as a research scientist at All-Russian Scientific Research Institute of Veterinary Virology and Microbiology of the Russian Academy of Agricultural Sciences, then he moved to Pharmaceutical Company LEKKO where he held key positions - from the Head of quality assurance department to the General Director.
Evgeny Stavnichy joined the NPO Microgen team in 2018 where he held the position of Deputy Director for Quality for the first year, and then was approved to the position of Deputy Director for Operations. From October 2019 to November 2020 he held the position of acting director at the Immunopreparat enterprise. In November 2020, according to the order of Andrei Zagorsky, General Director of Nacimbio, the managing organization of NPO Microgen, he was appointed Director of the subsidiary.
Under the management of Evgeny Stavnichy, the enterprise achieved the record production volume of influenza vaccine Sovigripp supplied for immunological prophylaxis within the National Preventive Immunization Schedule and finished the modernization of the site for Russian botulinum toxin production. The new director of the subsidiary also actively participates in the implementation of the project for bacteriophage-based drugs production optimization.
